https://www.prnewswire.com/news-releases/research-published-in-cell-reports-medicine-highlights-potential-of-akero-therapeutics-nash-therapeutic-candidate-301096697.html
Research Published in Cell Reports Medicine Highlights Potential of Akero Therapeutics' NASH...
/PRNewswire/ -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a cardio-metabolic, non-alcoholic steatohepatitis (NASH) company developing pioneering medicines...
cell reports medicineresearch published